Last viewed:
LUNG
Prices are updated after-hours
LUNG
|
$7.52
0.27%
0.27%
350K
|
Health Technology
(0.0% 1d)
(-22.0% 1m)
(-39.2% 1y)
(0.0% 2d)
(0.0% 3d)
(-0.5% 7d)
(-15.77%
volume)
Earnings Calendar: 2024-02-21
Market Cap: $ 289,800,917
http://www.pulmonx.com
Sec
Filling
|
Patents
| 180 employees
(US) Pulmonx Corp. provides interventional pulmonology, planning tools, and treatments for obstructive lung diseases. It carries out its operations in the following geographical locations: Europe, Middle East and Africa (EMEA), Asia Pacific, Other International, and United States. It offers the Zephyr Endobronchial Valve, an implantable device used to occlude all airways feeding the hyperinflated lobe of a lung that is most diseased with emphysema. It also offers StratX Lung Analysis, a platform designed to treat severe emphysema, and the Chartis Assessment System, a pulmonary assessment system. The company was founded by Rodney C. Perkins and is headquartered in Redwood City, CA.
seeds
lungs
treatment
add to watch list
Paper trade
email alert is off
Press-releases
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
Published: 2024-04-10
(Crawled : 20:00)
- globenewswire.com
LUNG
|
$7.52
0.27%
0.27%
350K
|
Health Technology
| -10.7%
| O: 0.12%
H: 0.84%
C: 0.24%
first
report
financial
results
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
Published: 2024-04-02
(Crawled : 20:00)
- globenewswire.com
RMD
|
$178.85
0.7%
0.0%
1.2M
|
Health Technology
| -5.71%
| O: 0.88%
H: 1.64%
C: 0.03%
LUNG
|
$7.52
0.27%
0.27%
350K
|
Health Technology
| -12.69%
| O: 0.59%
H: 1.64%
C: -7.13%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
| -7.2%
| O: -0.12%
H: 0.24%
C: -1.54%
financial
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-15
(Crawled : 21:00)
- globenewswire.com
LUNG
|
$7.52
0.27%
0.27%
350K
|
Health Technology
| Email alert
Add to watchlist
nasdaq
grants
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
Published: 2024-02-26
(Crawled : 15:30)
- biospace.com/
LUNG
|
$7.52
0.27%
0.27%
350K
|
Health Technology
| -31.27%
| O: -0.65%
H: 3.35%
C: -3.26%
aeriseal
first
treatment
system
trial
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-21
(Crawled : 21:00)
- globenewswire.com
LUNG
|
$7.52
0.27%
0.27%
350K
|
Health Technology
| -48.76%
| O: -2.07%
H: 0.0%
C: -16.48%
year
financial
results
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
Published: 2024-02-21
(Crawled : 21:00)
- globenewswire.com
BDX
|
$234.12
0.42%
0.0%
1.3M
|
Health Technology
| -5.83%
| O: -0.05%
H: 0.13%
C: -0.64%
LUNG
|
$7.52
0.27%
0.27%
350K
|
Health Technology
| -48.76%
| O: -2.07%
H: 0.0%
C: -16.48%
ceo
Lung Stent Market to reach $333.8 million, globally, by 2030 at 7.1% CAGR: Coherent Market Insights
Published: 2024-02-20
(Crawled : 15:30)
- prnewswire.com
LUNG
|
$7.52
0.27%
0.27%
350K
|
Health Technology
| -48.11%
| O: -0.49%
H: 2.46%
C: 1.12%
lung
reach
market
Billy, 75
Published: 2024-02-14
(Crawled : 15:00)
- pulmonx.com
LUNG
|
$7.52
0.27%
0.27%
350K
|
Health Technology
| -47.93%
| O: 1.26%
H: 1.73%
C: 1.38%
Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
Published: 2024-02-07
(Crawled : 21:00)
- globenewswire.com
LUNG
|
$7.52
0.27%
0.27%
350K
|
Health Technology
| -48.69%
| O: -0.14%
H: 0.28%
C: -0.97%
report
year
financial
results
Global Endobronchial Valves Market Size Predicted to Reach USD 284.76 Million By 2032, Growing at 5.9% CAGR: Report by Polaris Market Research
Published: 2024-01-16
(Crawled : 15:30)
- prnewswire.com
BSX
|
$67.33
-0.13%
-0.31%
7M
|
Health Technology
| 12.48%
| O: -0.22%
H: 1.13%
C: 0.74%
LUNG
|
$7.52
0.27%
0.27%
350K
|
Health Technology
| -41.63%
| O: -1.57%
H: 2.79%
C: 1.76%
report
million
reach
research
global
growing
market
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001415889-24-009142
4
2024-03-26
2024-03-22
Sell
S
1184
307868
0001415889-24-008639
4
2024-03-19
2024-03-15
Buy
A
425116
425116
0001415889-24-008639
4
2024-03-19
2024-03-15
Buy
A
205286
205286